Pfizer applies for full FDA approval of its COVID-19 vaccine
Pfizer and BioNTech announced this morning that they have applied for full approval with the U.S. Food and Drug Administration for their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older.
Share:
